Key Metrics
CiteScore 

4.4
SJR 

Q4Endocrinology

SNIP 

1.19
Recommended pre-submission checks
Powered by 

Topics Covered on European Endocrinology
European Endocrinology Journal Specifications
| Overview | |
| Publisher | Touch Medical Media |
Planning to publish in European Endocrinology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in European Endocrinology
Glucagon-like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth.
- 1 Jan 2023
- European Endocrinology
Resmetirom: An Orally Administered, Smallmolecule, Liver-directed, β-selective THR Agonist for the Treatment of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis.
- 1 Jan 2023
- European Endocrinology
Alarming Surge in Early-onset Type 2 Diabetes: A Global Catastrophe on the Horizon.
- 1 Jan 2023
- European Endocrinology
Surgical Treatment of Solitary Metachronous Adrenal Metastasis from Urothelial Carcinoma of the Urinary Bladder.
- 1 Jan 2023
- European Endocrinology
Emerging Evidence for the Use of Antidiabetic Drugs, Glucagon-like Peptide 1 Receptor Agonists, for the Treatment of Alzheimer's Disease.
- 1 Jan 2023
- European Endocrinology
An Overview of Risk Factors for Diabetic Foot Amputation: An Observational, Single-centre, Retrospective Cohort Study.
- 1 Jan 2023
- European Endocrinology
Glucagon-like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth.
- 1 Jan 2023
- European Endocrinology
Resmetirom: An Orally Administered, Smallmolecule, Liver-directed, β-selective THR Agonist for the Treatment of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis.
- 1 Jan 2023
- European Endocrinology
Alarming Surge in Early-onset Type 2 Diabetes: A Global Catastrophe on the Horizon.
- 1 Jan 2023
- European Endocrinology
Surgical Treatment of Solitary Metachronous Adrenal Metastasis from Urothelial Carcinoma of the Urinary Bladder.
- 1 Jan 2023
- European Endocrinology
Emerging Evidence for the Use of Antidiabetic Drugs, Glucagon-like Peptide 1 Receptor Agonists, for the Treatment of Alzheimer's Disease.
- 1 Jan 2023
- European Endocrinology
An Overview of Risk Factors for Diabetic Foot Amputation: An Observational, Single-centre, Retrospective Cohort Study.
- 1 Jan 2023
- European Endocrinology